Roche scoops up COVID test maker GenMark for $1.8B

In a deal that will boost its diagnostics products, Roche (OTCQX:RHHBF) has agreed to buy GenMark Diagnostics (NASDAQ:GNMK) for about $1.8B.The transaction is Roche’s largest since t… [+395 chars]read more